Decreased serum vitamin D levels are associated with diabetic peripheral neuropathy in a rural area of Turkey

Acta Neurologica Belgica

Volumn 115, Issue 1, 2015, Pages 47-52

  Celikbilek, Asuman ^a   Gocmen, Ayse Yesim ^a   Tanik, Nermin ^a   Borekci, Elif ^a   Adam, Mehmet ^a   Celikbilek, Mehmet ^a   Suher, Murat ^a   Delibas, Namik ^a  

^a BOZOK UNIVERSITY   (Turkey)

Author keywords

Diabetes; Diabetic peripheral neuropathy; Vitamin D; Vitamin D receptor; Vitamin D binding protein

Indexed keywords

GLUCOSE; VITAMIN D; VITAMIN D BINDING PROTEIN; VITAMIN D RECEPTOR; CALCITRIOL RECEPTOR;

ADULT; ARTICLE; CHEMICAL ANALYSIS; CONTROLLED STUDY; DIABETIC NEUROPATHY; DIABETIC PERIPHERAL NEUROPATHY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; OPHTHALMOSCOPY; PERIPHERAL NEUROPATHY; PROSPECTIVE STUDY; RETINOPATHY; RURAL AREA; TURKEY (REPUBLIC); AGED; BLOOD; CASE CONTROL STUDY; DIABETIC NEUROPATHIES; ELECTROMYOGRAPHY; MIDDLE AGED; NONPARAMETRIC TEST; TURKEY;

ADULT; AGED; CASE-CONTROL STUDIES; DIABETIC NEUROPATHIES; ELECTROMYOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; RECEPTORS, CALCITRIOL; STATISTICS, NONPARAMETRIC; TURKEY; VITAMIN D; VITAMIN D-BINDING PROTEIN;

EID: 84939416096     PISSN: 03009009     EISSN: 22402993     Source Type: Journal    
DOI: 10.1007/s13760-014-0304-0     Document Type: Article

References (41)

1. Holick MF (2007) Vitamin D deficiency. New Engl J Med 357(3):266–281. doi:10.1056/NEJMra070553
2. Makariou S, Liberopoulos EN, Elisaf M, Challa A (2011) Novel roles of vitamin D in disease: what is new in 2011? Eur J Intern Med 22(4):355–362. doi:10.1016/j.ejim.2011.04.012
3. Pierrot-Deseilligny C (2009) Clinical implications of a possible role of vitamin D in multiple sclerosis. J Neurol 256(9):1468–1479. doi:10.1007/s00415-009-5139-x
4. Smolders J, Thewissen M, Peelen E, Menheere P, Tervaert JW, Damoiseaux J, Hupperts R (2009) Vitamin D status is positively correlated with regulatory T cell function in patients with multiple sclerosis. PLoS One 4(8):e6635. doi:10.1371/journal.pone.0006635
5. Zipitis CS, Akobeng AK (2008) Vitamin D supplementation in early childhood and risk of type 1 diabetes: a systematic review and meta-analysis. Arch Dis Child 93(6):512–517. doi:10.1136/adc.2007.128579
6. The NS, Crandell JL, Lawrence JM, King IB, Dabelea D, Marcovina SM, D’Agostino RB Jr, Norris JM, Pihoker C, Mayer-Davis EJ (2013) Vitamin D in youth with type 1 diabetes: prevalence of insufficiency and association with insulin resistance in the SEARCH Nutrition Ancillary Study. Diabet Med 30(11):1324–1332. doi:10.1111/dme.12297
7. Tohidi M, Bozorgmanesh M, Mohebi R, Khalili D, Saadat N, Khorrami N, Azizi F, Hadaegh F (2013) Non-linear association between 25-hydroxyvitamin D and the incidence of type 2 diabetes: a community-based nested case-control study. Diabetic Med 30(8):934–938. doi:10.1111/Dme.12180
8. Pittas AG, Lau J, Hu FB, Dawson-Hughes B (2007) The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 92(6):2017–2029. doi:10.1210/jc.2007-0298
9. Argoff CE, Cole BE, Fishbain DA, Irving GA (2006) Diabetic peripheral neuropathic pain: clinical and quality-of-life issues. Mayo Clin Proc 81(4 Suppl):S3–S11
10. Girach A, Manner D, Porta M (2006) Diabetic microvascular complications: can patients at risk be identified? A review. Int J Clin Pract 60(11):1471–1483. doi:10.1111/j.1742-1241.2006.01175.x
11. Bell DS (2012) Reversal of the symptoms of diabetic neuropathy through correction of vitamin D deficiency in a type 1 diabetic patient. Case Rep Endocrinol 2012:165056. doi:10.1155/2012/165056
12. Soderstrom LH, Johnson SP, Diaz VA, Mainous AG (2012) Association between vitamin D and diabetic neuropathy in a nationally representative sample: results from 2001–2004 NHANES. Diabet Med 29(1):50–55. doi:10.1111/j.1464-5491.2011.03379.x
13. Shehab D, Al-Jarallah K, Mojiminiyi OA, Al Mohamedy H, Abdella NA (2012) Does vitamin D deficiency play a role in peripheral neuropathy in type 2 diabetes? Diabet Med 29(1):43–49. doi:10.1111/j.1464-5491.2011.03510.x
14. Skalli S, Muller M, Pradines S, Halimi S, Wion-Barbot N (2012) Vitamin D deficiency and peripheral diabetic neuropathy. Eur J Intern Med 23(2):e67–e68. doi:10.1016/j.ejim.2011.11.008
15. Lee P, Chen R (2008) Vitamin D as an analgesic for patients with type 2 diabetes and neuropathic pain. Arch Intern Med 168(7):771–772. doi:10.1001/archinte.168.7.771
16. Rhee SY, Hwang YC, Chung HY, Woo JT (2012) Vitamin D and diabetes in Koreans: analyses based on the Fourth Korea National Health and Nutrition Examination Survey (KNHANES), 2008–2009. Diabet Med 29(8):1003–1010. doi:10.1111/j.1464-5491.2012.03575.x
17. American Diabetes A (2009) Diagnosis and classification of diabetes mellitus. Diabetes Care 32(Suppl 1):S62–S67. doi:10.2337/dc09-S062
18. Singleton JR, Smith AG, Bromberg MB (2001) Increased prevalence of impaired glucose tolerance in patients with painful sensory neuropathy. Diabetes Care 24(8):1448–1453
19. Prakash S, Mehta NC, Dabhi AS, Lakhani O, Khilari M, Shah ND (2010) The prevalence of headache may be related with the latitude: a possible role of vitamin D insufficiency? J Headache Pain 11(4):301–307. doi:10.1007/s10194-010-0223-2
20. Bouhassira D, Attal N, Alchaar H, Boureau F, Brochet B, Bruxelle J, Cunin G, Fermanian J, Ginies P, Grun-Overdyking A, Jafari-Schluep H, Lanteri-Minet M, Laurent B, Mick G, Serrie A, Valade D, Vicaut E (2005) Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain 114(1–2):29–36. doi:10.1016/j.pain.2004.12.010
21. Chandy A, Pawar B, John M, Isaac R (2008) Association between diabetic nephropathy and other diabetic microvascular and macrovascular complications. Saudi J Kidney Dis Transpl 19(6):924–928
22. Petrone AB, Weir NL, Steffen BT, Tsai MY, Gaziano JM, Djousse L (2013) Plasma vitamin D-binding protein and risk of heart failure in male physicians. Am J Cardiol 112(6):827–830. doi:10.1016/j.amjcard.2013.05.014
23. Boucher BJ (2011) Vitamin D insufficiency and diabetes risks. Curr Drug Targets 12(1):61–87
24. George PS, Pearson ER, Witham MD (2012) Effect of vitamin D supplementation on glycaemic control and insulin resistance: a systematic review and meta-analysis. Diabet Med 29(8):e142–e150. doi:10.1111/j.1464-5491.2012.03672.x
25. Duncan BB, Schmidt MI, Pankow JS, Ballantyne CM, Couper D, Vigo A, Hoogeveen R, Folsom AR, Heiss G, Atherosclerosis Risk in Communities S (2003) Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes 52(7):1799–1805
26. Hewison M (2010) Vitamin D and the immune system: new perspectives on an old theme. Endocrinol Metab Clin North Am 39(2):365–379. doi:10.1016/j.ecl.2010.02.010 table of contents
27. Danescu LG, Levy S, Levy J (2009) Vitamin D and diabetes mellitus. Endocrine 35(1):11–17. doi:10.1007/s12020-008-9115-5
28. Borissova AM, Tankova T, Kirilov G, Dakovska L, Kovacheva R (2003) The effect of vitamin D3 on insulin secretion and peripheral insulin sensitivity in type 2 diabetic patients. Int J Clin Pract 57(4):258–261
29. Palomer X, Gonzalez-Clemente JM, Blanco-Vaca F, Mauricio D (2008) Role of vitamin D in the pathogenesis of type 2 diabetes mellitus. Diabetes Obes Metab 10(3):185–197. doi:10.1111/j.1463-1326.2007.00710.x
30. Riaz S, Malcangio M, Miller M, Tomlinson DR (1999) A vitamin D (3) derivative (CB1093) induces nerve growth factor and prevents neurotrophic deficits in streptozotocin-diabetic rats. Diabetologia 42(11):1308–1313. doi:10.1007/s001250051443
31. Garcion E, Wion-Barbot N, Montero-Menei CN, Berger F, Wion D (2002) New clues about vitamin D functions in the nervous system. Trends Endocrin Met 13(3):100–105. doi:10.1016/S1043-2760(01)00547-1
32. Plotnikoff GA, Quigley JM (2003) Prevalence of severe hypovitaminosis D in patients with persistent, nonspecific musculoskeletal pain. Mayo Clin Proc 78(12):1463–1470. doi:10.4065/78.12.1463
33. Valensi P, Le Devehat C, Richard JL, Farez C, Khodabandehlou T, Rosenbloom RA, LeFante C (2005) A multicenter, double-blind, safety study of QR-333 for the treatment of symptomatic diabetic peripheral neuropathy. A preliminary report. J Diabetes Complicat 19(5):247–253. doi:10.1016/j.jdiacomp.2005.05.011
34. Verboven C, Rabijns A, De Maeyer M, Van Baelen H, Bouillon R, De Ranter C (2002) A structural basis for the unique binding features of the human vitamin D-binding protein. Nat Struct Biol 9(2):131–136. doi:10.1038/nsb754
35. White P, Cooke N (2000) The multifunctional properties and characteristics of vitamin D-binding protein. Trends Endocrinol Metab 11(8):320–327
36. Nyomba BL, Bouillon R, Lissens W, Vanbaelen H, Demoor P (1985) 1,25-Dihydroxyvitamin-D and vitamin D-binding Protein are both decreased in streptozotocin-diabetic rats. Endocrinology 116(6):2483–2488
37. Chiu KC, Chu A, Go VLW, Saad MF (2004) Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 79(5):820–825
38. Chuang JC, Cha JY, Garmey JC, Mirmira RG, Repa JJ (2008) Research resource: nuclear hormone receptor expression in the endocrine pancreas. Mol Endocrinol 22(10):2353–2363. doi:10.1210/me.2007-0568
39. Choi M, Ozeki J, Hashizume M, Kato S, Ishihara H, Makishima M (2012) Vitamin D receptor activation induces peptide YY transcription in pancreatic islets. Endocrinology 153(11):5188–5199. doi:10.1210/en.2012-1396
40. Bland R, Markovic D, Hills CE, Hughes SV, Chan SL, Squires PE, Hewison M (2004) Expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in pancreatic islets. J Steroid Biochem Mol Biol 89–90(1–5):121–125. doi:10.1016/j.jsbmb.2004.03.115
41. Ordonez-Moran P, Munoz A (2009) Nuclear receptors: genomic and non-genomic effects converge. Cell Cycle 8(11):1675–1680